Autopsy report · NCT03593109

A Single-center Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LCAR-L10D Cell Formulations Targeting CD19 and CD22 in Patients With CD19- and/or CD22-Positive Relapsed/Refractory B-cell Lymphoma

“Suitable patients were not recruited”

The sponsor’s own words in the registry.

Life of this trial

• Registered 11 months before it started.
• Ran for about 1 year 11 months before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Second Affiliated Hospital of Xi'an Jiaotong University

Sponsor type

University, hospital or other

Conditions

Lymphoma, B-Cell

Interventions

Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy

Participants

1

Sites

1

Countries

China

Trials that died the same way

• Effect of Intensive Cognitive Rehabilitation on Cognitive, Motor, and Language Functional Networks in Subacute Stroke Patient
  “Patients not recruited.” (90% match in meaning)
• Xenogenic Keratoplasty From Porcine Cornea
  “there was not enough patients recruited in this study” (84% match in meaning)
• Osseous Setting Improvement With Co-implantation of Osseous Matrix and Mesenchymal Progenitors Cells From Autologous Bone Marrow
  “no recruited patients” (84% match in meaning)
• Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients
  “No patients recruited” (82% match in meaning)
• Bone Healing in Healthy and Post-menopausal Osteoporotic Women
  “Unable to recruit suitable patients” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.